Company News

April 2011

Promius Pharma and Valeant form collaboration to market Cloderm® Cream in the United States.

Click here for articlePDF

August 2009

Promius Pharma, LLC has announced the launch of Promisebâ„¢ Topical Cream, a non-steroidal, prescription only, cream for the treatment of seborrheic dermatitis, that has demonstrated both anti-inflammatory and antifungal properties.

Click here for articlePDF

January 2009

Promius Pharma, LLC, has launched Scytera™(coal tar) Foam 2% for the treatment of chronic psoriasis, a skin disease that affects approximately 7.5 million Americans according to The National Psoriasis Foundation.

Click here for articlePDF

September 18, 2008

Dr. Reddy's formally announces its US Specialty Business, Promius Pharma, LLC

Click here for articlePDF

September 03, 2008

Antares Pharma enters into a feasibility development agreement with Dr. Reddy's Laboratories for an enhanced dermatology product utilizing the ATD gel platform.

Click here for articlePDF

September 27, 2007

Sinclair Pharma plc announces Dr Reddy's Laboratories as Sebclair marketing partner in US.

Click here for articlePDF

January 24, 2007

Foamix signs R&D collaboration and license agreement with Dr. Reddy's for the development and commercialization of psoriasis foam.

Click here for articlePDF